BNGO Annual FCF
-$126.87 M
+$1.25 M+0.97%
31 December 2023
Summary:
As of January 19, 2025, BNGO annual free cash flow is -$126.87 million, with the most recent change of +$1.25 million (+0.97%) on December 31, 2023. During the last 3 years, it has fallen by -$88.56 million (-231.14%). BNGO annual FCF is now -525.74% below its all-time high of -$20.28 million, reached on December 31, 2018.BNGO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNGO Quarterly FCF
-$13.31 M
+$7.75 M+36.79%
01 September 2024
Summary:
As of January 19, 2025, BNGO quarterly free cash flow is -$13.31 million, with the most recent change of +$7.75 million (+36.79%) on September 1, 2024. Over the past year, it has increased by +$7.75 million (+36.79%). BNGO quarterly FCF is now -330.60% below its all-time high of -$3.09 million, reached on December 31, 2017.BNGO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNGO TTM FCF
-$93.05 M
+$13.06 M+12.31%
01 September 2024
Summary:
As of January 19, 2025, BNGO TTM free cash flow is -$93.05 million, with the most recent change of +$13.06 million (+12.31%) on September 1, 2024. Over the past year, it has increased by +$13.06 million (+12.31%). BNGO TTM FCF is now -1151.09% below its all-time high of -$7.44 million, reached on March 31, 2017.BNGO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNGO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.0% | +36.8% | +12.3% |
| 3 y3 years | -231.1% | +34.3% | -58.4% |
| 5 y5 years | -525.7% | -82.6% | -214.4% |
BNGO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -72.9% | +1.0% | at high | +64.2% | -26.8% | +31.5% |
| 5 y | 5-year | -328.8% | +1.0% | -84.4% | +64.2% | -214.4% | +31.5% |
| alltime | all time | -525.7% | +1.0% | -330.6% | +64.2% | -1151.1% | +31.5% |
Bionano Genomics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.31 M(-36.8%) | -$93.05 M(-12.3%) |
| June 2024 | - | -$21.05 M(-25.2%) | -$106.10 M(-13.2%) |
| Mar 2024 | - | -$28.16 M(-7.8%) | -$122.26 M(-3.6%) |
| Dec 2023 | -$126.87 M(-1.0%) | -$30.52 M(+15.8%) | -$126.87 M(-4.2%) |
| Sept 2023 | - | -$26.37 M(-29.1%) | -$132.43 M(-2.5%) |
| June 2023 | - | -$37.21 M(+13.5%) | -$135.82 M(+6.6%) |
| Mar 2023 | - | -$32.77 M(-9.2%) | -$127.42 M(-0.5%) |
| Dec 2022 | -$128.12 M(+74.6%) | -$36.08 M(+21.2%) | -$128.12 M(+7.9%) |
| Sept 2022 | - | -$29.76 M(+3.3%) | -$118.78 M(+8.7%) |
| June 2022 | - | -$28.80 M(-14.0%) | -$109.27 M(+17.6%) |
| Mar 2022 | - | -$33.48 M(+25.2%) | -$92.94 M(+26.6%) |
| Dec 2021 | -$73.39 M(+91.5%) | -$26.74 M(+32.0%) | -$73.39 M(+24.9%) |
| Sept 2021 | - | -$20.25 M(+62.4%) | -$58.75 M(+18.8%) |
| June 2021 | - | -$12.47 M(-10.5%) | -$49.46 M(+11.9%) |
| Mar 2021 | - | -$13.93 M(+15.1%) | -$44.21 M(+15.4%) |
| Dec 2020 | -$38.31 M | -$12.10 M(+10.4%) | -$38.31 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$10.96 M(+51.8%) | -$35.61 M(+11.5%) |
| June 2020 | - | -$7.22 M(-10.1%) | -$31.94 M(+2.8%) |
| Mar 2020 | - | -$8.03 M(-14.6%) | -$31.07 M(+5.0%) |
| Dec 2019 | -$29.59 M(+45.9%) | -$9.40 M(+29.0%) | -$29.59 M(+21.8%) |
| Sept 2019 | - | -$7.29 M(+14.8%) | -$24.29 M(+4.6%) |
| June 2019 | - | -$6.35 M(-3.1%) | -$23.23 M(+16.0%) |
| Mar 2019 | - | -$6.55 M(+59.7%) | -$20.03 M(-1.2%) |
| Dec 2018 | -$20.28 M(-7.1%) | -$4.10 M(-34.2%) | -$20.28 M(+5.2%) |
| Sept 2018 | - | -$6.23 M(+98.2%) | -$19.26 M(+1.6%) |
| June 2018 | - | -$3.14 M(-53.8%) | -$18.96 M(-10.5%) |
| Mar 2018 | - | -$6.80 M(+120.0%) | -$21.20 M(-2.9%) |
| Dec 2017 | -$21.84 M(-12.1%) | -$3.09 M(-47.9%) | -$21.84 M(+16.5%) |
| Sept 2017 | - | -$5.93 M(+10.2%) | -$18.74 M(+46.3%) |
| June 2017 | - | -$5.38 M(-27.7%) | -$12.82 M(+72.3%) |
| Mar 2017 | - | -$7.44 M | -$7.44 M |
| Dec 2016 | -$24.85 M | - | - |
FAQ
- What is Bionano Genomics annual free cash flow?
- What is the all time high annual FCF for Bionano Genomics?
- What is Bionano Genomics annual FCF year-on-year change?
- What is Bionano Genomics quarterly free cash flow?
- What is the all time high quarterly FCF for Bionano Genomics?
- What is Bionano Genomics quarterly FCF year-on-year change?
- What is Bionano Genomics TTM free cash flow?
- What is the all time high TTM FCF for Bionano Genomics?
- What is Bionano Genomics TTM FCF year-on-year change?
What is Bionano Genomics annual free cash flow?
The current annual FCF of BNGO is -$126.87 M
What is the all time high annual FCF for Bionano Genomics?
Bionano Genomics all-time high annual free cash flow is -$20.28 M
What is Bionano Genomics annual FCF year-on-year change?
Over the past year, BNGO annual free cash flow has changed by +$1.25 M (+0.97%)
What is Bionano Genomics quarterly free cash flow?
The current quarterly FCF of BNGO is -$13.31 M
What is the all time high quarterly FCF for Bionano Genomics?
Bionano Genomics all-time high quarterly free cash flow is -$3.09 M
What is Bionano Genomics quarterly FCF year-on-year change?
Over the past year, BNGO quarterly free cash flow has changed by +$7.75 M (+36.79%)
What is Bionano Genomics TTM free cash flow?
The current TTM FCF of BNGO is -$93.05 M
What is the all time high TTM FCF for Bionano Genomics?
Bionano Genomics all-time high TTM free cash flow is -$7.44 M
What is Bionano Genomics TTM FCF year-on-year change?
Over the past year, BNGO TTM free cash flow has changed by +$13.06 M (+12.31%)